197 related articles for article (PubMed ID: 7685403)
1. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.
van Grunsven WM; van Heerde EC; de Haard HJ; Spaan WJ; Middeldorp JM
J Virol; 1993 Jul; 67(7):3908-16. PubMed ID: 7685403
[TBL] [Abstract][Full Text] [Related]
2. Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease.
Fachiroh J; Stevens SJ; Haryana SM; Middeldorp JM
J Virol Methods; 2010 Oct; 169(1):79-86. PubMed ID: 20621126
[TBL] [Abstract][Full Text] [Related]
3. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein.
van Grunsven WM; Spaan WJ; Middeldorp JM
J Infect Dis; 1994 Jul; 170(1):13-9. PubMed ID: 8014488
[TBL] [Abstract][Full Text] [Related]
4. Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex.
van Grunsven WM; Nabbe A; Middeldorp JM
J Med Virol; 1993 Jun; 40(2):161-9. PubMed ID: 8395556
[TBL] [Abstract][Full Text] [Related]
5. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
[TBL] [Abstract][Full Text] [Related]
6. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
Lin SF; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
J Virol; 1997 Apr; 71(4):3069-76. PubMed ID: 9060668
[TBL] [Abstract][Full Text] [Related]
7. Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21).
Serio TR; Angeloni A; Kolman JL; Gradoville L; Sun R; Katz DA; Van Grunsven W; Middeldorp J; Miller G
J Virol; 1996 Nov; 70(11):8047-54. PubMed ID: 8892929
[TBL] [Abstract][Full Text] [Related]
8. Detection of human serum antibodies to the BFRF3 Epstein-Barr virus capsid component by means of a DNA-binding assay.
Shedd D; Angeloni A; Niederman J; Miller G
J Infect Dis; 1995 Nov; 172(5):1367-70. PubMed ID: 7594680
[TBL] [Abstract][Full Text] [Related]
9. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
10. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
Cho MS; Gissmann L; Hayward SD
Virology; 1984 Aug; 137(1):9-19. PubMed ID: 6089423
[TBL] [Abstract][Full Text] [Related]
12. Serodiagnosis of Epstein-Barr virus infection by using recombinant viral capsid antigen fragments and autologous gene fusion.
Hinderer W; Lang D; Rothe M; Vornhagen R; Sonneborn HH; Wolf H
J Clin Microbiol; 1999 Oct; 37(10):3239-44. PubMed ID: 10488185
[TBL] [Abstract][Full Text] [Related]
13. Inclusion bodies of recombinant Epstein-Barr virus capsid antigen p18 as potential immobilized antigens in enzyme immunoassays for detection of nasopharyngeal carcinoma.
Lim CS; Goh SL; Kariapper L; Krishnan G; Lim YY; Ng CC
Clin Chim Acta; 2015 Aug; 448():206-10. PubMed ID: 26164385
[TBL] [Abstract][Full Text] [Related]
14. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of cDNA clones corresponding to transcripts from the BamHI G region of the Epstein-Barr virus genome and expression of BGLF2.
Chen MR; Hsu TY; Lin SW; Chen JY; Yang CS
J Gen Virol; 1991 Dec; 72 ( Pt 12)():3047-55. PubMed ID: 1662696
[TBL] [Abstract][Full Text] [Related]
16. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
17. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
Pearson GR; Luka J; Petti L; Sample J; Birkenbach M; Braun D; Kieff E
Virology; 1987 Sep; 160(1):151-61. PubMed ID: 2820125
[TBL] [Abstract][Full Text] [Related]
18. Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.
Leung SF; Tam JS; Chan AT; Zee B; Chan LY; Huang DP; Van Hasselt A; Johnson PJ; Lo YM
Clin Chem; 2004 Feb; 50(2):339-45. PubMed ID: 14684618
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.
Dong L; Masaki Y; Takegami T; Kawanami T; Itoh K; Jin ZX; Huang CR; Tong XP; Fukushima T; Tanaka M; Sawaki T; Sakai T; Sugai S; Okazaki T; Hirose Y; Umehara H
Int Immunol; 2007 Mar; 19(3):331-6. PubMed ID: 17272286
[TBL] [Abstract][Full Text] [Related]
20. [Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma].
Yi B; Gu YL; Zong YS; Cheng WM; Ji MF
Ai Zheng; 2009 Aug; 28(8):822-6. PubMed ID: 19664327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
